• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症患者的癌症风险及其与糖尿病的关联:一项基于两个中心的研究。

Cancer Risk and its Association With Diabetes Mellitus in Patients With Acromegaly: A Two Center-based Study.

作者信息

Xiao Zhe-Hao, Wang Cheng, Wang Yong, Yuan Shang-Kun, Huang Cheng, Chen Ren-Fang, Li Yong

机构信息

Department of medical oncology, The First Affiliated Hospital of Nanchang University, Nanchang, China.

Emergency Department, The Second Affiliated Hospital of Nanchang University, Nanchang, China.

出版信息

Endocr Pract. 2023 Sep;29(9):699-704. doi: 10.1016/j.eprac.2023.06.005. Epub 2023 Jun 19.

DOI:10.1016/j.eprac.2023.06.005
PMID:37343764
Abstract

OBJECTIVE

To compare the incidence of cancer in patients with acromegaly with that of the local population in China and explore possible risk factors.

METHODS

Data from 117 patients diagnosed with acromegaly at 2 centers between 2011 and 2022 were analyzed, and their cancer diagnoses were recorded. The cancer standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) were calculated by comparison with those of the local population. The patients were divided into 2 groups, having cancer diagnosis or not. The relationships between cancer and sex, body mass index, age, growth hormone levels, diagnosis delay, tumor size, disease duration, treatment, disease status, and other comorbidities were analyzed.

RESULTS

Eight (6.8%) of 117 patients were diagnosed with cancer. The incidence of overall (SIR = 3.29, 95% CI = 1.42-6.94), colorectal (SIR = 16.67, 95% CI = 4.45-42.67), and thyroid cancers (SIR = 14.29, 95% CI = 1.73-51.60) was increased, but that of lung cancer (SIR = 4.17, 95% CI = 0.50-15.05) was not. Diagnostic delay (10.1[8.6-14.3] vs 3.8[1.3-9.0]; P = .005) and duration of acromegaly (12.8[8.9-16.4] vs 5.6[2.3-10.9]; P = .008) were prolonged in the cancer group. Diabetes mellitus (odds ratio = 7.01, 95% CI = 1.23-39.99) was an independent risk factor for acromegaly with cancer.

CONCLUSION

Acromegaly patients are at a higher risk of cancer and its association with diabetes mellitus. Considering the rarity of the disease, an Acromegaly Cancer Registry Center should be established in China as soon as possible.

摘要

目的

比较中国肢端肥大症患者与当地人群的癌症发病率,并探讨可能的危险因素。

方法

分析了2011年至2022年间在2个中心诊断为肢端肥大症的117例患者的数据,并记录了他们的癌症诊断情况。通过与当地人群进行比较,计算癌症标准化发病率(SIR)和95%置信区间(CI)。将患者分为有癌症诊断和无癌症诊断两组。分析癌症与性别、体重指数、年龄、生长激素水平、诊断延迟、肿瘤大小、病程、治疗、疾病状态及其他合并症之间的关系。

结果

117例患者中有8例(6.8%)被诊断为癌症。总体癌症(SIR = 3.29,95% CI = 1.42 - 6.94)、结直肠癌(SIR = 16.67,95% CI = 4.45 - 42.67)和甲状腺癌(SIR = 14.29,95% CI = 1.73 - 51.60)的发病率升高,但肺癌(SIR = 4.17,95% CI = 0.50 - 15.05)的发病率未升高。癌症组的诊断延迟(10.1[8.6 - 14.3]对3.8[1.3 - 9.0];P = 0.005)和肢端肥大症病程(12.8[8.9 - 16.4]对5.6[2.3 - 1有癌症的肢端肥大症患者的独立危险因素。

结论

肢端肥大症患者患癌症的风险较高,且与糖尿病有关。考虑到该疾病的罕见性,中国应尽快建立肢端肥大症癌症登记中心。.9];P = 0.008)延长。糖尿病(优势比 = 7.01,95% CI = 1.23 - 39.99)是肢端肥大症合并癌症的独立危险因素。

结论

肢端肥大症患者患癌症的风险较高,且与糖尿病有关。考虑到该疾病的罕见性,中国应尽快建立肢端肥大症癌症登记中心。

相似文献

1
Cancer Risk and its Association With Diabetes Mellitus in Patients With Acromegaly: A Two Center-based Study.肢端肥大症患者的癌症风险及其与糖尿病的关联:一项基于两个中心的研究。
Endocr Pract. 2023 Sep;29(9):699-704. doi: 10.1016/j.eprac.2023.06.005. Epub 2023 Jun 19.
2
Incidence and risk factors of cancers in acromegaly: a Chinese single-center retrospective study.肢端肥大症患者癌症的发病情况及相关危险因素:一项中国单中心回顾性研究。
Endocrine. 2023 Nov;82(2):368-378. doi: 10.1007/s12020-023-03447-y. Epub 2023 Jul 13.
3
Acromegaly and cancer risk: a cohort study in Sweden and Denmark.肢端肥大症与癌症风险:瑞典和丹麦的一项队列研究
Cancer Causes Control. 2002 Jun;13(5):395-400. doi: 10.1023/a:1015713732717.
4
Risk of cancer in acromegaly patients: An updated meta-analysis and systematic review.肢端肥大症患者的癌症风险:一项更新的荟萃分析和系统评价。
PLoS One. 2023 Nov 30;18(11):e0285335. doi: 10.1371/journal.pone.0285335. eCollection 2023.
5
The Incidence of Cancer Among Acromegaly Patients: Results From the German Acromegaly Registry.肢端肥大症患者的癌症发病率:来自德国肢端肥大症登记处的结果。
J Clin Endocrinol Metab. 2015 Oct;100(10):3894-902. doi: 10.1210/jc.2015-2372. Epub 2015 Aug 5.
6
Cancer prevalence and cancer screening in patients with acromegaly: a single center experience.肢端肥大症患者的癌症患病率和癌症筛查:单中心经验。
Endocrine. 2022 Aug;77(2):363-371. doi: 10.1007/s12020-022-03082-z. Epub 2022 May 24.
7
Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry.肢端肥大症中的糖尿病:患病率、风险因素和演变:来自法国肢端肥大症登记处的数据。
Eur J Endocrinol. 2011 Jun;164(6):877-84. doi: 10.1530/EJE-10-1050. Epub 2011 Apr 4.
8
Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature.肢端肥大症患者的癌症发病率:一项队列研究和文献荟萃分析。
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2182-2188. doi: 10.1210/jc.2017-02457.
9
Incidence of Benign and Malignant Tumors in Patients With Acromegaly Is Increased: A Nationwide Population-based Study.肢端肥大症患者良性和恶性肿瘤的发病率增加:一项基于全国人口的研究。
J Clin Endocrinol Metab. 2021 Nov 19;106(12):3487-3496. doi: 10.1210/clinem/dgab560.
10
Acromegaly is associated with increased cancer risk: a survey in Italy.肢端肥大症与癌症风险增加相关:意大利的一项调查。
Endocr Relat Cancer. 2017 Sep;24(9):495-504. doi: 10.1530/ERC-16-0553. Epub 2017 Jul 14.

引用本文的文献

1
Editorial: Cancer risk in patients with acromegaly - is extensive screening needed?社论:肢端肥大症患者的癌症风险——是否需要进行全面筛查?
Front Endocrinol (Lausanne). 2024 Oct 28;15:1503633. doi: 10.3389/fendo.2024.1503633. eCollection 2024.
2
Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management.肢端肥大症患者的糖尿病:病理生理学、临床挑战与管理
Nat Rev Endocrinol. 2024 Sep;20(9):541-552. doi: 10.1038/s41574-024-00993-x. Epub 2024 Jun 6.